Plain-English translation of NCT05801471 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to better understand how glaucoma—a disease that damages the optic nerve and causes vision loss—changes over time. This study will follow 200 patients with glaucoma for three years, using different types of eye tests to measure changes in vision and the structure of the eye. The goal is to figure out which testing methods work best for tracking whether glaucoma is getting worse.
Currently, doctors use different approaches to monitor glaucoma progression, but there's no clear agreement on which methods are most reliable. This research aims to settle that question by comparing how well different eye tests can detect when glaucoma is advancing, so patients get the most accurate monitoring possible.
You likely qualify if…
You likely don't qualify if…
Over 36 months, you will visit the clinic regularly for eye examinations. At each visit, you'll receive three types of tests: two different visual field tests (which measure your side vision and overall visual function) and an optical coherence tomography scan (a special imaging test that shows the structure of your eye). There are no medications or procedures involved—just non-invasive eye scans to track how your glaucoma changes over time.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Italy
Sponsor
Centervue SpA
Enrollment target
~200 participants
Started
May 2022
Primary completion
November 2028
Age range
40 Years – 90 Years
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Chiara Rui
Clinica oculistica Ospedale San Paolo
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.